The campaign aims to vaccinate 6,000,000 girls and boys between the ages of 3 and 11.
–
The President of the Argentine Pediatric Society (SAP), Omar Tabacco, I endorse this Tuesday the inoculation against coronavirus for children between 3 and 11 years of age with the Sinopharm vaccine, which he “recommended” after having had access to the scientific evidence available to the Ministry of Health.
“We want the boys to be vaccinated, for their safety, to achieve herd immunity and to reinforce school attendance. Without a doubt, we recommend the vaccine,” said Tabacco in statements made this morning to Radio Nacional.
The specialist acknowledged that the announcement made from the Ministry of Health last Friday, in relation to the vaccination of 6,000,000 girls and boys between 3 and 11 years old “took him by surprise,” that is why the entity met with the Ministry to see “what was the scientific evidence that they had, since they were not published.”
In dialogue with Radio Nacional, Tabacco expressed that “There was information that we did not have and both parents and our colleagues needed certainty.”
Likewise, the head of the pediatric entity emphasized that prior to the meeting with the authorities of the Ministry of Health and Education, “all we had was a publication of the British medical journal Lancet, with very good results in phase one and two, working on one three, but due to confidentiality these results are closed until the end of the study, but the Anmat has access to these data, that is why it authorized it “.
The SAP confirmed that it received the data on the tests carried out with Sinopharm and highlighted the work of the Anmat.
–
In that sense, Tabacco stressed that the National Administration of Medicines, Food and Medical Technology (Anmat), “is a serious, prestigious and absolutely trustworthy entity.”
On the other hand, the specialist said that the Ministry of Health showed the authorities of the SAP “the path that Anmat has traveled with the regulatory entities of China and the laboratory that produces the vaccine, in the surveillance of a study of phase three of the use of Sinopharm for this age group, and other statistical results of a potential regrowth of (the variant) Delta (of the coronavirus) “.
Faced with this scenario, the president of the SAP indicated that the vaccination plan for boys and girls “will be two doses as in adults” and stated that “the initiative is to actively vaccinate in schools.”
“That is why the team from the Ministry of Education was part of the meeting”He added in relation to yesterday’s meeting at the headquarters of the Health portfolio.
– .
